BioHarvest Sciences Inc.
BHST
$4.21
-$0.04-0.94%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -0.01% | 6.48% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.01% | 6.48% | |||
| Cost of Revenue | 9.84% | 1.98% | |||
| Gross Profit | -6.19% | 9.52% | |||
| SG&A Expenses | -0.20% | -9.09% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.00% | -3.32% | |||
| Operating Income | -21.85% | 49.31% | |||
| Income Before Tax | 7.43% | 39.37% | |||
| Income Tax Expenses | -201.59% | 61.54% | |||
| Earnings from Continuing Operations | 12.30% | 38.41% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 12.30% | 38.41% | |||
| EBIT | -21.85% | 49.31% | |||
| EBITDA | -87.85% | 62.00% | |||
| EPS Basic | 28.50% | 38.77% | |||
| Normalized Basic EPS | 24.57% | 39.71% | |||
| EPS Diluted | 28.50% | 38.77% | |||
| Normalized Diluted EPS | 24.57% | 39.71% | |||
| Average Basic Shares Outstanding | 22.71% | 0.56% | |||
| Average Diluted Shares Outstanding | 22.71% | 0.56% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||